Home Depot (The) vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
World's largest home improvement retailer; $159.5B FY2024 revenue; $18.25B SRS Distribution acquisition expands Pro specialty distribution by $50B TAM; Pro now ~50% of revenues.
About
The Home Depot is the world's largest home improvement retailer, founded in 1978 by Bernie Marcus, Arthur Blank, Ron Brill, and Pat Farrah in Atlanta, Georgia, and now headquartered in Atlanta and trading on NYSE (HD). The company operates approximately 2,340 stores across the United States, Canada, and Mexico and generated approximately $159.5 billion in total revenues for fiscal year 2024 (ending January 2025) under CEO Ted Decker. The strategic anchor of 2024 was the completed $18.25 billion acquisition of SRS Distribution—a leading professional roofing, pool, and landscaping products distributor—which dramatically expands Home Depot's reach into the professional contractor market and extends its addressable market by an estimated $50 billion in professional specialty trade distribution.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.